Publications in Nature 2023 : a new drug prevents EMT, metastasis and resistance to anti-cancer therapy

Pharmacological targeting of netrin-1 inhibits EMT in cancer.
Lengrand J, Pastushenko I, Vanuytven S, Song Y, Venet D, Sarate RM, Bellina M, Moers V, Boinet A, Sifrim A, Rama N, Ducarouge B, Van Herck J, Dubois C, Scozzaro S, Lemaire S, Gieskes S, Bonni S, Collin A, Braissand N, Allard J, Zindy E, Decaestecker C, Sotiriou C, Salmon I, Mehlen P, Voet T, Bernet A, Blanpain C.
Nature. 2023 Aug 2. doi: 10.1038/s41586-023-06372-2.
Pubmed  PDF

Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Cassier PA, Navaridas R, Bellina M, Rama N, Ducarouge B, Hernandez-Vargas H, Delord JP, Lengrand J, Paradisi A, Fattet L, Garin G, Gheit H, Dalban C, Pastushenko I, Neves D, Jelin R, Gadot N, Braissand N, Léon S, Degletagne C, Matias-Guiu X, Devouassoux-Shisheboran M, Mery-Lamarche E, Allard J, Zindy E, Decaestecker C, Salmon I, Perol D, Dolcet X, Ray-Coquard I,Blanpain C*, Bernet A*, Mehlen P* (*last co-authors)
Nature. 2023 Aug 2. doi: 10.1038/s41586-023-06367-z.
Pubmed  PDF

Press highlights
ULB press release
Centre Léon Bérard press release
RTBF
Le Vif
Le Soir (August 2)
Europe1
France info
Femme actuelle
Le Specialiste
Daily Science
Telesambre
News-Medical-Life-Sciences
BX1
Le Soir (August18)
Le Figaro (link to paid version)
Le Progrès (link to paid version)

Publication in Nature 2023 : RHOJ controls EMT-associated resistance to chemotherapy

RHOJ controls EMT-associated resistance to chemotherapy.
Debaugnies M, Rodriguez-Acebes S, Blondeau J, Parent MA, Zocco M, Song Y, Latil M, Dubois C, Moers M, Impens F, Van Haver D, Rorive S, Allard J, Uemura A, Sotiropoulou PA, Salmon I, Méndez J, Blanpain C.
Nature 2023. https://doi.org/10.1038/s41586-023-05838-7
Pubmed PDF

Press highlights
ULB press release
Le Soir
La Libre
RTBF
Daily Science
Bioworld 
Esprit Libre

Yura Song at the Young scientist special session

Yura Song (PhD student in bioinformatics), was selected to be one of the twelve speakers of the Young scientist special session, which was co-organized by Stanford University, K-bioX (a non-profit organization of Korean scientists in USA), Department of Pharmacy – Seoul National University, College of Medicine – Catholic university of Korea, College of Medicine – Chungang University (all are located in Seoul, Korea)​.  She got third prize with the paper “NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation. Federico Mauri, Corentin Schepkens,…and Cédric Blanpain. Nature Cancer, volume 2, pages 1152–1169 (2021).

Publication in Nature Cell Biology 2022 : Mesp1 controls the chromatin and enhancer landscapes essential for spatiotemporal patterning of early cardiovascular progenitors

Mesp1 controls the chromatin and enhancer landscapes essential for spatiotemporal patterning of early cardiovascular progenitors.
Lin X, Swedlund B, Ton MN, Ghazanfar S, Guibentif C, Paulissen C, Baudelet E, Plaindoux E, Achouri Y, Calonne E, Dubois C, Mansfield W, Zaffran S, Marioni JC, Fuks F, Göttgens B, Lescroart F, Blanpain C.
Nat Cell Biol. 2022 Jul;24(7):1114-1128. doi: 10.1038/s41556-022-00947-3. Epub 2022 Jul 11.PMID: 35817961
Pubmed PDF

Press highlights
ULB press release
La Libre Belgique

Spanish Order of Civil Merit awarded to the lab

On June 16, H.E. Ambassador of Spain in Belgium awarded the laboratory the Orden del Mérito Civil (Order of Civil Merit).  She wanted to highlight the discoveries made by the laboratory on the Fat1 gene, thanks to the collaboration with many Spanish hospitals.